SCHEMBL6549488

SCHEMBL6549488

Nc1nc2ncn(Cc3ccc4ccccc4c3)c2c(=O)n1Cc1ccc2c(c1)OCO2

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 4/20 0.45
ALDH1A1 P00352 6/20 0.45
KMT2A Q03164 3/20 0.45
MEN1 O00255 2/20 0.45
NPSR1 Q6W5P4 2/20 0.44
RAB9A P51151 1/20 0.44
HIF1A Q16665 1/20 0.44
HPGD P15428 2/20 0.44
POLB P06746 1/20 0.41
RXFP1 Q9HBX9 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
PKM P14618 1/20 0.41
TSHR P16473 1/20 0.41
KDM4E B2RXH2 1/20 0.41
USP2 O75604 1/20 0.41
MAPT P10636 1/20 0.41
TP53 P04637 1/20 0.40
CDC25A P30304 1/20 0.40
CDC25B P30305 1/20 0.40
CYP1A2 P05177 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6797064 0.89 GAA (0.43) ALDH1A1HIF1APOLBSMN1; SMN2GAA
SCHEMBL7110371 0.85 ALDH1A1 (0.47) PDE5AALDH1A1KMT2AMEN1NPSR1
SCHEMBL6796275 0.82 KMT2A (0.47) ALDH1A1KMT2AHIF1AHPGDSMN1; SMN2
SCHEMBL6801426 0.82 MCHR1 (0.39) ALDH1A1HIF1ASMN1; SMN2GAA
SCHEMBL6549181 0.82 TRPA1 (0.38) ALDH1A1HIF1APOLBSMN1; SMN2GAA
SCHEMBL6549287 0.82 GAA (0.40) ALDH1A1KMT2AMEN1RAB9AHIF1A
SCHEMBL6550065 0.81 MMP13 (0.42) ALDH1A1HIF1ARXFP1SMN1; SMN2GAA
SCHEMBL6548972 0.81 GAA (0.41) ALDH1A1KMT2AMEN1HPGDSMN1; SMN2
SCHEMBL6549145 0.80 GAA (0.52) ALDH1A1KMT2AMEN1RXFP1SMN1; SMN2
SCHEMBL6548067 0.80 L3MBTL1 (0.47) PDE5AKMT2AMEN1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040138212-A1 Disubstituted 1,7-guanines PHARMACIA ITALIA, S.P.A. (IT) 2004-07-15 US claimed
US-20040138212-A1 Disubstituted 1,7-guanines PHARMACIA ITALIA, S.P.A. (IT) 2004-07-15 US disclosed
EP-1383766-A1 DISUBSTITUTED 1,7-GUANINES Pharmacia Italia S.p.A. (IT) 2004-01-28 EP disclosed
WO-2002090357-A1 DISUBSTITUTED 1,7-GUANINES PHARMACIA ITALIA S.P.A. (IT) 2002-11-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040138212-A1 Disubstituted 1,7-guanines GDA, UNG, TYMS PDE5A 1208/4885ALDH1A1 2138/4885KMT2A 1497/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.